Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prostate cancer screening using risk stratification based on a multi-state model of genetic variants.

The Prostate - 1 Jun 2015

Yen Amy Ming-Fang, Auvinen Anssi, Schleutker Johanna, Wu Yi-Ying, Fann Jean Ching-Yuan, Tammela Teuvo, Chen Sam Li-Sheng, Chiu Sherry Yueh-Hsia, Chen Hsiu-Hsi

Abstract excerpt

BACKGROUND: Risk-stratified screening for prostate cancer (PCa) with prostate-specific antigen (PSA) testing incorporating genetic variants has received some attention but has been scarcely investigated. We developed a model to stratify the Finnish population by different risk profiles related to genetic variants to optimize the screening policy. METHODS: Data from the Finnish randomized controlled trial on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Finland

Share to Markov Chains

Share to Monte Carlo Method

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 25683204
DOI: 10.1002/pros.22964

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prostate cancer screening using risk stratification based on a multi-state model of genetic variants.PMID 25683204Read ↗

Prostate cancer risk prediction using a polygenic risk score.Semantic proximity Read ↗

Precision Prostate Cancer Screening with a Polygenic Risk ScoreSemantic proximity Read ↗

A genetic risk score to guide age-specific, personalized prostate cancer screeningSemantic proximity Read ↗

Improved prostate cancer prediction by combining Prostate-Specific Antigen (PSA) test results with Genetic Risk Scores (GRS/PRS)Semantic proximity Read ↗

Risk of prostate cancer in relatives of prostate cancer patients in Sweden: A nationwide cohort study.Semantic proximity Read ↗

The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial.Semantic proximity Read ↗

Joint modelling of PSA dynamics and prostate cancer risks: A population-based studySemantic proximity Read ↗

Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms.Semantic proximity Read ↗

Risk stratification in men with a negative prostate biopsy: an interim analysis of a prospective cohort study.Semantic proximity Read ↗

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.Semantic proximity Read ↗

Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.Semantic proximity Read ↗

Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.